|

Adebrelimab;decitabine; Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Tianjin Medical University Cancer Institute and Hospital1

Indications

  • Decitabine1
  • Adebrelimab (SHR-1316)1
  • Metastatic Pancreatic Cancer1
  • Cancer1

Other1 trial

Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.